Form 4: Aurinia Pharmaceuticals CFO Sells Shares to Cover Tax Obligations

Joseph M. Miller, CFO of Aurinia Pharmaceuticals, sold 34,811 shares of common stock on March 6, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 6, 2024, Joseph M. Miller, the Chief Financial Officer of Aurinia Pharmaceuticals Inc., sold 34,811 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units granted on March 2, 2022, and March 2, 2023.
• The shares were sold at a weighted average price of $5.6, with individual transactions ranging from $5.475 to $5.755.
• Following the transaction, Miller directly owns 495,928 shares of Aurinia Pharmaceuticals Inc.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily indicate a change in the CFO's confidence in the company.

Industry Context

This is a routine Form 4 filing related to insider transactions. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates